Petredis Investment Advisors LLC grew its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 0.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 33,529 shares of the company’s stock after buying an additional 133 shares during the period. Petredis Investment Advisors LLC’s holdings in Procter & Gamble were worth $5,807,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in the stock. Itau Unibanco Holding S.A. purchased a new stake in Procter & Gamble during the 2nd quarter worth $28,000. Fairway Wealth LLC purchased a new stake in Procter & Gamble during the 2nd quarter worth $29,000. Ruedi Wealth Management Inc. boosted its position in Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after purchasing an additional 77 shares during the period. POM Investment Strategies LLC purchased a new stake in Procter & Gamble during the 2nd quarter worth $34,000. Finally, Quest Partners LLC purchased a new position in Procter & Gamble in the 2nd quarter valued at about $36,000. 65.77% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the sale, the chief financial officer now owns 37,208 shares in the company, valued at approximately $6,325,360. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CFO Andre Schulten sold 13,041 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now directly owns 37,208 shares in the company, valued at $6,325,360. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 383,194 shares of company stock worth $65,140,718. 0.17% of the stock is owned by company insiders.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. During the same quarter in the prior year, the business earned $1.37 earnings per share. Procter & Gamble’s quarterly revenue was down .1% on a year-over-year basis. As a group, sell-side analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current year.
Procter & Gamble Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.32%. Procter & Gamble’s payout ratio is currently 65.69%.
Wall Street Analyst Weigh In
PG has been the subject of a number of analyst reports. JPMorgan Chase & Co. upped their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Citigroup upped their price objective on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Finally, Piper Sandler started coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price on the stock. Nine analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $176.21.
View Our Latest Report on Procter & Gamble
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- Top Biotech Stocks: Exploring Innovation Opportunities
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- 3 Warren Buffett Stocks to Buy Now
- AMD Gains Momentum With AI: Can It Beat Expectations?
- Trading Stocks: RSI and Why it’s Useful
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.